The signal involved invasive lobular carcinoma (ILC), a subtype affecting ~48K Americans each year.
ILC has long been considered “immune cold,” with relatively low immune activity. AutoDiscovery found more activity than expected.
AI’s biggest role in science may not be answering questions. It may be helping scientists find which questions are worth asking.
At Providence Swedish, AutoDiscovery surfaced an unexpected immune signal in a heavily studied cancer dataset—and follow-up research confirmed it. 🧵
buff.ly/LTacUQl